S&P 500   2,997.87 (+1.07%)
DOW   27,036.90 (+0.93%)
QQQ   193.36 (+1.18%)
AAPL   235.89 (+0.01%)
MSFT   141.44 (+1.35%)
GOOGL   1,240.65 (+1.88%)
CGC   19.99 (+5.99%)
NVDA   198.56 (+6.45%)
MU   46.30 (+3.21%)
TSLA   259.27 (+0.90%)
AMD   30.65 (+0.39%)
T   37.87 (+1.07%)
DIS   129.80 (+0.08%)
S&P 500   2,997.87 (+1.07%)
DOW   27,036.90 (+0.93%)
QQQ   193.36 (+1.18%)
AAPL   235.89 (+0.01%)
MSFT   141.44 (+1.35%)
GOOGL   1,240.65 (+1.88%)
CGC   19.99 (+5.99%)
NVDA   198.56 (+6.45%)
MU   46.30 (+3.21%)
TSLA   259.27 (+0.90%)
AMD   30.65 (+0.39%)
T   37.87 (+1.07%)
DIS   129.80 (+0.08%)
Log in

Sartorius Stock Price, News & Analysis (FRA:SRT3)

€173.70
+2.40 (+1.40 %)
(As of 10/15/2019 12:44 PM ET)
Today's Range
€171.10
Now: €173.70
€174.70
50-Day Range
€159.90
MA: €171.44
€183.00
52-Week Range
€71.00
Now: €173.70
€124.70
Volume67,940 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors. Read More…

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-551-3080

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees8,500
Next Earnings DateN/A
OptionableNot Optionable

Receive SRT3 News and Ratings via Email

Sign-up to receive the latest news and ratings for SRT3 and its competitors with MarketBeat's FREE daily newsletter.


Sartorius (FRA:SRT3) Frequently Asked Questions

What is Sartorius' stock symbol?

Sartorius trades on the FRA under the ticker symbol "SRT3."

What price target have analysts set for SRT3?

9 equities research analysts have issued 12 month price targets for Sartorius' shares. Their forecasts range from €97.50 to €184.00. On average, they expect Sartorius' stock price to reach €146.50 in the next twelve months. This suggests that the stock has a possible downside of 15.7%. View Analyst Price Targets for Sartorius.

What is the consensus analysts' recommendation for Sartorius?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sartorius in the last year. There are currently 5 sell ratings and 4 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Sartorius.

Has Sartorius been receiving favorable news coverage?

News headlines about SRT3 stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Sartorius earned a daily sentiment score of -1.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Sartorius.

Who are some of Sartorius' key competitors?

What other stocks do shareholders of Sartorius own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius investors own include Symrise (SY1), Osram Licht (OSR), Merck KGaA (MRK), Kion Group (KGX), Henkel AG & Co KGaA (HEN3), Deutsche Telekom (DTE), Allianz (ALV), adidas (ADS), Volkswagen (VOW3) and Daimler (DAI).

Who are Sartorius' key executives?

Sartorius' management team includes the folowing people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 54)
  • Mr. Rainer Lehmann, CFO & Member of Exec. Board and Head of Fin., Information Technology & Bus. Process (Age 43)
  • Ms. Petra Kirchhoff, Head of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 50)
  • Mr. Gerry Mackay, Head of Lab Products & Services Division & Member of Exec. Board (Age 56)
  • Dr. René Fáber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 43)

What is Sartorius' stock price today?

One share of SRT3 stock can currently be purchased for approximately €173.70.

What is Sartorius' official website?

The official website for Sartorius is http://www.sartorius.de/.

How can I contact Sartorius?

Sartorius' mailing address is Weender Landstrasse 94-108, GOETTINGEN, 37075, Germany. The company can be reached via phone at +49-551-3080.


MarketBeat Community Rating for Sartorius (FRA SRT3)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  95 (Vote Outperform)
Underperform Votes:  139 (Vote Underperform)
Total Votes:  234
MarketBeat's community ratings are surveys of what our community members think about Sartorius and other stocks. Vote "Outperform" if you believe SRT3 will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRT3 will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel